Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes
The available treatments for patients affected by Alzheimer’s disease (AD) are not curative. Numerous clinical trials have failed during the past decades. Therefore, scientists need to explore new avenues to tackle this disease. In the present review, we briefly summarize the pathological mechanisms...
Main Authors: | Marta Valenza, Roberta Facchinetti, Giorgia Menegoni, Luca Steardo, Caterina Scuderi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/4/600 |
Similar Items
-
Looking for a Treatment for the Early Stage of Alzheimer’s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin
by: Roberta Facchinetti, et al.
Published: (2020-05-01) -
The role of astrocytes in amyloid production and Alzheimer's disease
by: Georgia R. Frost, et al.
Published: (2017-01-01) -
Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in an In Vitro Model of Alzheimer’s Disease
by: Roberta Facchinetti, et al.
Published: (2022-05-01) -
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
by: Deepali Singh
Published: (2022-08-01) -
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes
by: Luca eSteardo, et al.
Published: (2015-07-01)